ClaroNav, a Toronto, Canada-based surgical navigation technology company, closed its first external equity financing round.
The company sold over C$2M of common shares at a pre-money valuation of C$52M to selected distributors, customers, suppliers, friends and employees.
The company plans to use these funds to continue to innovate and expand global marketing, training, sales and support activities for its flagship Navident product.
Founded by Claudio Gatti and his partner Doron Dekel in 2001, ClaroNav develops, manufactures and markets MicronTracker, a family of optical tracking systems, Navident, a dental navigation system, and Navient, a family of cranial navigation systems. Navident is a dental navigation system which uses volumetric medical images (CBCT) and real-time optical motion tracking to help dentists place implants more precisely, and less invasively.
FinSMEs
21/02/2020